AI English summary of an SEC filing — figures as filed
Colgate-Palmolive CLThe company said full-year 2025 net sales rose 1.4% to $20,382 million, and GAAP diluted EPS fell 25% to $2.63. Base Business EPS increased 3% to $3.69.
Key points
AI summaryThe company said full-year 2025 net sales rose 1.4% to $20,382 million, and GAAP diluted EPS fell 25% to $2.63. Base Business EPS increased 3% to $3.69.
The company said it recorded a non-cash, after-tax charge of $794 million in Q4 to adjust the carrying values of goodwill and intangible assets related to the skin health business. It cited lower-than-expected category growth and weaker-than-expected performance, particularly in China, as reasons it lowered its outlook for the skin health business, primarily Filorga.
Colgate-Palmolive said net sales for Q4 2025 rose 5.8% to $5,230 million, and organic sales increased 2.2%. GAAP EPS for the quarter was $(0.05), and Base Business EPS was $0.95.
The company said net cash provided by operations for the full year 2025 was a record $4,198 million, and it returned $2.9 billion to shareholders through dividends and share repurchases. Free cash flow before dividends was $3,634 million.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Full-year net sales $20,382 million, GAAP diluted EPS $2.63
The company said full-year 2025 net sales rose 1.4% to $20,382 million, and GAAP diluted EPS fell 25% to $2.63. Base Business EPS increased 3% to $3.69.
Source · Based on the filing body and exhibits
Skin health goodwill and intangibles impairment $794 million
The company said it recorded a non-cash, after-tax charge of $794 million in Q4 to adjust the carrying values of goodwill and intangible assets related to the skin health business. It cited lower-than-expected category growth and weaker-than-expected performance, particularly in China, as reasons it lowered its outlook for the skin health business, primarily Filorga.
Source · Based on the filing body and exhibits
Q4 net sales up 5.8%, GAAP EPS $(0.05)
Colgate-Palmolive said net sales for Q4 2025 rose 5.8% to $5,230 million, and organic sales increased 2.2%. GAAP EPS for the quarter was $(0.05), and Base Business EPS was $0.95.
Source · Based on the filing body and exhibits
Operating cash flow $4,198 million, shareholder returns $2.9 billion
The company said net cash provided by operations for the full year 2025 was a record $4,198 million, and it returned $2.9 billion to shareholders through dividends and share repurchases. Free cash flow before dividends was $3,634 million.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…